MYGN compared with IRWD: revenue, margins and what each company keeps, and the suppliers and customers both name

MYGNMyriad Genetics Inc

Mkt capRevenueRevenue

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

MYGNMyriad Genetics Inc

IRWDIronwood Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

MYGNMyriad Genetics Inc

5.86▼−7.73%· post 5.86

Mkt cap$607.4MRevenue$191MQ2 FY26Revenue$825MFY25

IRWDIronwood Pharmaceuticals Inc

3.47▼−1.00%· post 3.47

ClosedNov 2 '26

Mkt cap$578.3MRevenue$113MQ2 FY26Revenue$296MFY25

Compare

ClosedNov 2 '26

MYGNMyriad Genetics Inc

IRWDIronwood Pharmaceuticals Inc

5.86▼−7.73%post 5.86

Price

3.47▼−1.00%post 3.47

$607.4M

Mkt cap

$578.3M

Q2 FY26$191M

Revenue

$113MQ2 FY26

FY25$825M

Revenue

$296MFY25

MYGN5.86▼−7.73%vsIRWD3.47▼−1.00%ClosedNov 2 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MYGN: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MYGN 8

UNHUnitedHealthcarecustomer

BNRBurning Rock Biotechcustomer

—Pathomiqunlistedsupplier

—Sophia Geneticsunlistedsupplier

4 more · MYGN chain ›

Shared 0

No shared counterparties.

Only IRWD 8

ABBVAbbViesupplier

AZNAstraZeneca ABcustomer

—Ferringunlistedsupplier

—Cour

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

supplier

4 more · IRWD chain ›

Price

rebased to 0%

MYGN, solidIRWD, dashed